BioRestorative Therapies, Inc. - FORM 10-K - EX-32 - EXHIBIT 32 - April 16, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.Financial_Report.xls
EX-14 - EXHIBIT 14 - BioRestorative Therapies, Inc.v308966_ex14.htm
EX-3.1 - EXHIBIT 3.1 - BioRestorative Therapies, Inc.v308966_ex3-1.htm
EX-3.2 - EXHIBIT 3.2 - BioRestorative Therapies, Inc.v308966_ex3-2.htm
EX-10.4 - EXHIBIT 10.4 - BioRestorative Therapies, Inc.v308966_ex10-4.htm
EX-31.1 - EXHIBIT 31.1 - BioRestorative Therapies, Inc.v308966_ex31-1.htm
EX-31.2 - EXHIBIT 31.2 - BioRestorative Therapies, Inc.v308966_ex31-2.htm
EX-10.45 - EXHIBIT 10.45 - BioRestorative Therapies, Inc.v308966_ex10-45.htm
EX-10.46 - EXHIBIT 10.46 - BioRestorative Therapies, Inc.v308966_ex10-46.htm
EX-10.48 - EXHIBIT 10.48 - BioRestorative Therapies, Inc.v308966_ex10-48.htm
EX-10.47 - EXHIBIT 10.47 - BioRestorative Therapies, Inc.v308966_ex10-47.htm
EX-10.13 - EXHIBIT 10.13 - BioRestorative Therapies, Inc.v308966_ex10-13.htm
EX-10.27 - EXHIBIT 10.27 - BioRestorative Therapies, Inc.v308966_ex10-27.htm
EX-10.49 - EXHIBIT 10.49 - BioRestorative Therapies, Inc.v308966_ex10-49.htm
EX-10.17 - EXHIBIT 10.17 - BioRestorative Therapies, Inc.v308966_ex10-17.htm
EX-10.50 - EXHIBIT 10.50 - BioRestorative Therapies, Inc.v308966_ex10-50.htm
EX-10.52 - EXHIBIT 10.52 - BioRestorative Therapies, Inc.v308966_ex10-52.htm
EX-10.44 - EXHIBIT 10.44 - BioRestorative Therapies, Inc.v308966_ex10-44.htm
10-K - FORM 10-K - BioRestorative Therapies, Inc.v308966_10k.htm
EX-10.51 - EXHIBIT 10.51 - BioRestorative Therapies, Inc.v308966_ex10-51.htm

  EXHIBIT 32

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

 

AND PRINCIPAL FINANCIAL OFFICER

 

PURSUANT TO

 

18 U.S.C. SECTION 1350,

 

AS ADOPTED PURSUANT TO

 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to 18 U.S.C. § 1350, the undersigned officer of BioRestorative Therapies, Inc. (the “Company”) hereby certifies that the Company’s Annual Report on Form 10-K for the year ended December 31, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: April 16, 2012 /s/ Mark Weinreb
  Mark Weinreb
  Principal Executive Officer and
  Principal Financial Officer

 

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report or as a separate disclosure document.

 

 

 

 

 

 

BioRestorative Therapies, Inc. Reports